Stryker has completed its acquisition of Becton Dickinson's CareFusion portfolio of vertebral compression fracture products. The deal, struck in March 2015, is the latest in Stryker's M&A rampage, and the fourth acquisition closed this month.
Auris Surgical Robotics said it will buy minimally invasive robotic surgery company Hansen Medical in a deal valued at about $80 million.
Chinese TAVR player buys German third-gen peer, aims for global market after $37M from Goldman Sachs
Venus Medtech aims to have the first transcatheter aortic valve implantation system cleared by the China Food and Drug Administration (CFDA). It also has a transcatheter pulmonic valve that is finishing clinical trials, which would also be a first for the CFDA.
Orthopedics implant and spine player Stryker has acquired Florida-based startup SafeWire in order to add to its minimally invasive spinal surgery products. Stryker has been on an M&A tear of late--this deal follows the closure of three acquisitions earlier this month.
UPDATED: VCs build biggest Brazilian med tech via two acquisitions, infuse with $21M and add ex-GE exec
Adavium Medical has made a lot of moves fast to thrust itself into the position of the largest medical equipment and diagnostics company in Brazil. It just acquired two of the largest Brazilian clinical diagnostics companies, raised a $21 million Series C round to finance these and other anticipated deals, hired an ex-GE Healthcare exec as COO and president of diagnostics and changed its name from Advance Medical.
Contract sterilization player Sterigenics, which was acquired last year in a deal reportedly valued at $2 billion by private equity firms Warburg Pincus and GTCR, has bought Nelson Laboratories. The deal wraps the largest U.S. sterility testing services for medical devices, pharmaceuticals and tissues into the Warburg portfolio company--making it the largest provider globally of sterilization services and testing, according to the company.
Adding to its healthcare heft, WPP Group bought CMI, a healthcare media agency that counts 10 of the largest 20 pharma advertisers among its clients.
Affymetrix, a maker of advanced genetic analysis technology, has rejected an unsolicited bid by former executives in favor of the $1.3 billion offer it received from Thermo Fisher Scientific earlier this year.
Precision for Medicine has signed a deal to acquire ACT Oncology--a leading CRO in the field of cancer studies--as together the new company looks to become a leading light in the personalized cancer clinical trial space.
UPDATED: Thermo Fisher CEO urges Affymetrix shareholders to sign off on $1.3B deal despite rival bid
Thermo Fisher Scientific CEO Marc Casper has a message to Affymetrix stockholders about its planned $1.3 billion buyout of gene editing firm: Make the right decision.